GeneDx (WGS) said Monday it expects fiscal Q4 revenue of $121 million.
Analysts polled by FactSet expect $120.4 million.
For full year 2025, the company said it expects total revenue of $427 million.
Analysts surveyed by FactSet expect $427 million.
The company also said it expects 2026 revenue of between $540 million and $555 million.
Analysts polled by FactSet expect $529.2 million.
GeneDx said it will report its Q4 results on Feb. 23 before the US market opens.
Shares of the company were down 8.4% in recent Monday premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments